Julia Wang A.'s Insider Trades & SAST Disclosures
Julia Wang A.'s most recent trade in Laboratory Corp. Of America Holdings was a trade of 7,800 Non-qualified Stock Options done . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Julia Wang A..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Laboratory Corp. Of Americ...
|
Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 7,800 | 7,800 | - | - | Non-qualified Stock Options | |
|
Laboratory Corp. Of Americ...
|
Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,580 | 4,367 | - | - | Restricted Stock Unit | |
|
Laboratory Corp. Of Americ...
|
Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 893 (0%) | 0% | - | Common Stock | |
|
Laboratory Corp. Of Americ...
|
Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 1,787 | - | - | Restricted Stock Unit | |
|
Laboratory Corp. Of Americ...
|
Julia Wang A. | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 336 | 557 (0%) | 0% | 247.7 | 83,241 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges